TY - JOUR
T1 - Differential stereoselectivity of D- and L-myo-inositol 1,2,4,5-tetrakisphosphate binding to the inositol 1,4,5-trisphosphate receptor and 3-kinase
AU - Suh, Byung Chang
AU - Kim, Myung Jun
AU - Choi, Gildon
AU - Choi, Kwan Yong
AU - Han, Jin Kwan
AU - Chung, Sung Kee
AU - Kim, Kyong Tai
PY - 2000/7/1
Y1 - 2000/7/1
N2 - D- and L-myo-inositol 1,2,4,5-tetrakisphosphate (Ins(1,2,4,5)P4) were investigated for their ability to bind to the D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) receptor in a bovine adrenal cortical membrane fraction, to mobilize intracellular Ca2+ stores in Xenopus oocytes, and to bind to the rat brain Ins(1,4,5)P3 3-kinase overexpressed and purified in E. coli. In competitive binding experiments with the Ins(1,4,5)P3 receptor, D-Ins(1,2,4,5)P4 effectively displaced [3H]Ins(1,4,5)P3 in a concentration-dependent manner with a potency comparable to that of D-Ins(1,4,5)P3, while L-Ins(1,2,4,5)P4 was ~50-fold less effective than D-Ins(1,4,5)P3 and D-Ins(1,2,4,5)P4. The DL-Ins(1,2,4,5)P4 racemate bound to the Ins(1,4,5)P3 receptor with an apparent intermediate efficiency. Injection of D-Ins(1,2,4,5)P4 into oocytes evoked a chloride current dependent on intracellular Ca2+ mobilization in which the agonists ranked in a similar order of potency as in the Ins(1,4,5)P3 receptor binding. On the other hand, D-Ins(1,2,4,5)P4 only inhibited the binding of [3H]Ins(1,4,5)P3 to 3-kinase very weakly with a markedly reduced potency compared to D-Ins(1,4,5)P3, indicating that D-Ins(1,2,4,5)P4 is not an effective competitor in the phosphorylation of [3H]-Ins(1,4,5)P3 by 3-kinase. The results, therefore, clearly indicate that D-Ins(1,2,4,5)P4 is as effective as D-Ins(1,4,5)P3 in the binding to the receptor but not 3-kinase, and access of Ins(1,2,4,5)P4 over the Ins(1,4,5)P3 receptor calls for stringent stereospecificity with D-Ins(1,2,4,5)P4 being the active form in DL-Ins(1,2,4,5)P4-mediated Ca2+ mobilization. Copyright (C) 2000 Elsevier Science Ltd.
AB - D- and L-myo-inositol 1,2,4,5-tetrakisphosphate (Ins(1,2,4,5)P4) were investigated for their ability to bind to the D-myo-inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) receptor in a bovine adrenal cortical membrane fraction, to mobilize intracellular Ca2+ stores in Xenopus oocytes, and to bind to the rat brain Ins(1,4,5)P3 3-kinase overexpressed and purified in E. coli. In competitive binding experiments with the Ins(1,4,5)P3 receptor, D-Ins(1,2,4,5)P4 effectively displaced [3H]Ins(1,4,5)P3 in a concentration-dependent manner with a potency comparable to that of D-Ins(1,4,5)P3, while L-Ins(1,2,4,5)P4 was ~50-fold less effective than D-Ins(1,4,5)P3 and D-Ins(1,2,4,5)P4. The DL-Ins(1,2,4,5)P4 racemate bound to the Ins(1,4,5)P3 receptor with an apparent intermediate efficiency. Injection of D-Ins(1,2,4,5)P4 into oocytes evoked a chloride current dependent on intracellular Ca2+ mobilization in which the agonists ranked in a similar order of potency as in the Ins(1,4,5)P3 receptor binding. On the other hand, D-Ins(1,2,4,5)P4 only inhibited the binding of [3H]Ins(1,4,5)P3 to 3-kinase very weakly with a markedly reduced potency compared to D-Ins(1,4,5)P3, indicating that D-Ins(1,2,4,5)P4 is not an effective competitor in the phosphorylation of [3H]-Ins(1,4,5)P3 by 3-kinase. The results, therefore, clearly indicate that D-Ins(1,2,4,5)P4 is as effective as D-Ins(1,4,5)P3 in the binding to the receptor but not 3-kinase, and access of Ins(1,2,4,5)P4 over the Ins(1,4,5)P3 receptor calls for stringent stereospecificity with D-Ins(1,2,4,5)P4 being the active form in DL-Ins(1,2,4,5)P4-mediated Ca2+ mobilization. Copyright (C) 2000 Elsevier Science Ltd.
KW - Calcium mobilization
KW - D-myo-inositol 1,2,4,5-tetrakisphosphate (1,2,4,5)P)
KW - Ins(1,4,5)P 3-kinase
KW - Ins(1,4,5)P receptor
UR - http://www.scopus.com/inward/record.url?scp=0034237214&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034237214&partnerID=8YFLogxK
U2 - 10.1016/S0197-0186(00)00004-8
DO - 10.1016/S0197-0186(00)00004-8
M3 - Article
C2 - 10781844
AN - SCOPUS:0034237214
SN - 0197-0186
VL - 37
SP - 47
EP - 52
JO - Neurochemistry International
JF - Neurochemistry International
IS - 1
ER -